Global Burden of cardiomyopathy and myocarditis in the older adults from 1990 to 2019

被引:7
|
作者
Zhang, Kexin [1 ,2 ]
Cheng, Xuebing [1 ,2 ]
Qu, Na [1 ,2 ,3 ]
Song, Hongwei [1 ,2 ]
Luo, Youhong [1 ,2 ]
Ye, Tongtong [1 ,2 ]
Xu, Qian [1 ,2 ]
Tian, Hongzhan [1 ,2 ]
Kan, Chengxia [1 ,2 ]
Hou, Ningning [1 ,2 ]
机构
[1] Weifang Med Univ, Dept Endocrinol & Metab, Affiliated Hosp, Weifang, Peoples R China
[2] Weifang Med Univ, Clin Res Ctr, Affiliated Hosp, Weifang, Peoples R China
[3] Weifang Med Univ, Dept Pathol, Affiliated Hosp, Weifang, Peoples R China
基金
中国国家自然科学基金;
关键词
aging; chronic disease; cardiomyopathy; myocarditis; older adults; incidence; ASSOCIATION; STATEMENT; HYPERTENSION; MANAGEMENT; CARDIOLOGY; EDUCATION; SOCIETY;
D O I
10.3389/fpubh.2022.1018385
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundCardiomyopathy and myocarditis (CM-MC) are common chronic diseases causing heart failure in older adults. We aimed to analyze the burden of CM-MC in older adults aged 60-89 years at the global, regional, and national levels in 204 countries from 1990 to 2019. MethodsDetailed data on CM-MC from 1990 to 2019 were analyzed from the Global Burden of Diseases Study 2019, including incidence, mortality, disability-adjusted life years (DALYs) and the proportion of deaths caused by different risks factors. All results are presented as numbers, age-standardized rates per 100,000 person-years and estimated annual percentage change (EAPC) with an uncertainty interval of 95%. ResultsGlobally, there were 475,458 (339,942-638,363) incidence cases from CM-MC in 2019; with an age-standardized incidence rate (ASIR) of 16 (13-19.3) per 100,000 person-years. And there were 185,308 (154,610-200,448) deaths, with the age-standardized mortality rate (ASMR) being 4.4 (3.7-4.8). CM-MC resulted in 3,372,716 (2,931,247-3,693,622) DALYs, with an age-standardized DALYs rate (ASDR) of 114.8 (98.7-126.1). Estimated annual percentage change (EAPCs) for ARIS, ARMS, and ARDS has decreased. At the national level, the United States of America had the highest mortality [21,372 (18,924-24,241)] and disability-adjusted life years [407,712 (370,234-470,165)]. And China had the highest number of incident cases [122, 266 (85,925-166,095)]. Globally, high systolic blood pressure and alcohol consumption were the top two risk factors for the proportion of CM-MC deaths. ConclusionCM-MC is still an important cause of early death and chronic disability in older adults. Based on this study, public health agencies should seek more effective methods to prevent and treat CM-MC.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Global, regional, and national burden of multiple sclerosis from 1990 to 2019: Findings of global burden of disease study 2019
    Qian, Zhen
    Li, Yuancun
    Guan, Zhiqiang
    Guo, Pi
    Zheng, Ke
    Du, Yali
    Yin, Shengjie
    Chen, Binyao
    Wang, Hongxi
    Jiang, Jiao
    Qiu, Kunliang
    Zhang, Mingzhi
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [42] Global trends in the burden of esophageal cancer, 1990-2019 Results from the Global Burden of Disease Study 2019
    Jiang, Yu
    Lin, Yuechun
    Wen, Yaokai
    Fu, Wenhai
    Wang, Rui
    He, Jiaxi
    Zhang, Jianrong
    Wang, Zhufeng
    Ge, Fan
    Huo, Zhenyu
    Wang, Runchen
    Peng, Haoxin
    Wu, Xiangrong
    He, Jianxing
    Li, Shuben
    JOURNAL OF THORACIC DISEASE, 2023, 15 (02) : 348 - +
  • [43] Global, regional and national burden of orofacial clefts from 1990 to 2019: an analysis of the Global Burden of Disease Study 2019
    Wang, Dawei
    Zhang, Boyu
    Zhang, Qi
    Wu, Yiping
    ANNALS OF MEDICINE, 2023, 55 (01)
  • [44] Global Burden of Nonalcoholic Fatty Liver Disease, 1990 to 2019 Findings From the Global Burden of Disease Study 2019
    Jiang, Wei
    Mao, Xianhua
    Liu, Zhenqiu
    Zhang, Tiejun
    Jin, Li
    Chen, Xingdong
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2023, 57 (06) : 631 - 639
  • [45] The global burden and associated factors of ovarian cancer in 1990–2019: findings from the Global Burden of Disease Study 2019
    Shiwen Zhang
    Chen Cheng
    Zejian Lin
    Linzi Xiao
    Xin Su
    Lu Zheng
    Yingjun Mu
    Minqi Liao
    Ruiqing Ouyang
    Wanlin Li
    Junrong Ma
    Jun Cai
    Lu Liu
    Donghong Wang
    Fangfang Zeng
    Jun Liu
    BMC Public Health, 22
  • [46] Global, Regional, and National Burden of Urolithiasis from 1990 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019
    Zhang, Lu
    Zhang, Xu
    Pu, Yuanchun
    Zhang, Yaodong
    Fan, Jinhai
    CLINICAL EPIDEMIOLOGY, 2022, 14 : 971 - 983
  • [47] Global Burden of Dementia Death from 1990 to 2019, with Projections to 2050: An Analysis of 2019 Global Burden of Disease Study
    Li, Z.
    Yang, N.
    He, L.
    Wang, J.
    Yang, Y.
    Ping, F.
    Xu, L.
    Zhang, Huabing
    Li, Wei
    Li, Yuxiu
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2024, 11 (04): : 1013 - 1021
  • [48] The burden of aortic aneurysm in China from 1990 to 2019: findings from the Global Burden of Disease Study 2019
    Hou, Xinran
    Zhang, Fan
    Ye, Zhi
    Xu, Qian
    Huang, Lingjin
    Guo, Qulian
    Liu, Wei
    Wang, Lijun
    Zhou, Maigeng
    Yin, Peng
    Zhu, Maoen
    BMC PUBLIC HEALTH, 2022, 22 (01)
  • [49] The burden of aortic aneurysm in China from 1990 to 2019: findings from the Global Burden of Disease Study 2019
    Xinran Hou
    Fan Zhang
    Zhi Ye
    Qian Xu
    Lingjin Huang
    Qulian Guo
    Wei Liu
    Lijun Wang
    Maigeng Zhou
    Peng Yin
    Maoen Zhu
    BMC Public Health, 22
  • [50] Burden of oral cancer in Asia from 1990 to 2019: Estimates from the Global Burden of Disease 2019 study
    Xie, Long
    Shang, Zhengjun
    PLOS ONE, 2022, 17 (03):